TLC Biopharmaceuticals Inc：Contact Us
Contact Us
About
https://www.tlcbio.com
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that ...
About
https://www.tlcbio.com
Hong co-founded Hermes Biosciences, Inc. and served as its Chief Scientific Officer from 1999 to 2005. Before venturing into the world of drug development, Dr.
Home
https://www.tlcbio.com
About TLC. TLC is dedicated to the research, development, and commercialization of best-in-class novel lipid nanoparticle (LNP)-based medicines · Technology.
Pipeline
https://www.tlcbio.com
Our Pipeline ; Pain Management · TLC590 · Local anesthetic. Devel. PH I PH II PH III Marketed ; Ophthalmology · TLC399 · Macular edema. Devel. PH I PH II PH III ...
TLC BioSciences
https://www.linkedin.com
We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases. Effective drug development is a challenging ...
TLC
https://www.tlcbio.com
研發重點. 台微體®專精於奈米藥物研發，其獨步全球之Lipid-Assembled Delivery (LipAD®) 藥物傳輸系統能降低藥物副作用及提升藥物療效，達到長效緩釋或標靶傳輸之效果.
台灣微脂體股份有限公司
https://www.chinabiz.org.tw
母公司關係企業. 編號 1; 子公司名稱 TLC Biopharmaceuticals Japan Co., Ltd.
台灣微脂體股份有限公司
https://www.104.com.tw
【公司簡介】資本額：6億4027萬元、員工數：120人。台灣微脂體公司(Taiwan Liposome Company, TLC)成立於1997年。公司之理...。公司位於台北市南港區。
媒體-期刊發表
https://www.tlcbio.com
, TLC Biopharmaceuticals Inc., Taiwan Liposome Company (TLC), Ltd. 已發表 ... TLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA; Taiwan ...